All

PerkinElmer Acquires Covaris to Create Diagnostics and Life Sciences Platform

PerkinElmer's acquisition of Covaris aims to help expand PerkinElmer’s life sciences portfolio into the high-growth diagnostics end market.

All

PerkinElmer’s New BioQule NGS System Automates Library Preparation

PerkinElmer launched the research use only BioQule NGS System, an automated benchtop solution for NGS library prep of up to eight samples.

All

Partnership Increases Accessibility to Covid-19 Tests in NYC

PerkinElmer, Inc. has announced its collaboration with the Mount Sinai Health System to increase accessibility of SARS-CoV-2 testing in New York City.

Euroimmun Launches Novel Ultrafast Automated Microscope

Mar 17, 2021 | Microscopy

Euroimmun’s EuroPattern Microscope Live compact immunofluorescence microscope is available with EuroLabOffice 4.0 laboratory management software.

PerkinElmer Launches Rapid Covid-19 Antigen Test

Feb 24, 2021 | Covid 19

The lateral flow immunoassay test can be used to screen or to aid in diagnoses of covid-19 in asymptomatic or symptomatic individuals.

Choosing Reference Standards for Molecular Assay Development

Feb 24, 2021 | Cancer, Molecular Diagnostics

Rapid adoption of molecular testing in cancer necessitates quality cell line-derived controls.

PerkinElmer Joins European Alliance for Newborn Screening in Spinal Muscular Atrophy

Jan 27, 2021 | Cerebrovascular, Company News

The alliance aims to make Spinal Muscular Atrophy testing mandatory in European newborn screening programs by 2025.

PerkinElmer Covid-19 Assay Gets FDA EUA for Asymptomatic Testing

Jan 15, 2021 | Covid 19, Molecular Diagnostics

The PerkinElmer New Coronavirus Nucleic Acid Detection Kit received EUA from the FDA to test individuals without symptoms or other reasons to suspect covid-19 infection.

PerkinElmer to Acquire Oxford Immunotec Global

Jan 8, 2021 | Company News, Tuberculosis

Through this acquisition, PerkinElmer will grow its portfolio of advanced infectious disease testing solutions to include tuberculosis detection.

Novel ELISA for Detection of SARS-CoV-2 Antigen in Acutely Infected Covid-19 Patients

Dec 16, 2020 | Covid 19, Immunoassay Reagents & test Kits

EuroImmun’s CE-marked Antigen ELISA is able to be applied in semi quantitative automatable detection of the SARS-CoV-2 nucleocapsid protein on a large scale.

EuroImmun Launches PCR Test to Differentiate Covid-19 and Flu

Dec 15, 2020 | Covid 19, Flu & Respiratory Infections

The new EuroRealTime test allows fast detection and differentiation of genetic material from SARS-CoV-2, influenza virus type A, and influenza virus type B using throat swab samples of patients with acute symptoms.

PerkinElmer Covid-19 RT-PCR Assay Gets CE Mark for Saliva, Sample Pooling

Dec 4, 2020 | Covid 19

The assay received CE-IVD marking for the use of saliva as specimen type and the option to pool up to five specimens collected from individuals suspected of covid-19 or asymptomatic individuals.